Catalysts for Takeda Pharmaceuticals USA Inc

MESALAMINE — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ANAGRELIDE HYDROCHLORIDE — FDA approval

ANAGRELIDE HYDROCHLORIDE — FDA approval

LIVTENCITY (MARIBAVIR) — FDA approval

ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval

UNIVERSITY OF TX MD ANDERSON CAN CTR — Project Title: Low-dose erlotinib and mesalamine for prevention of colitis-as...

VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval

ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval

VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

LIVTENCITY (MARIBAVIR) — FDA approval

ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval

ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval

VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

LIVTENCITY (MARIBAVIR) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval

LIVTENCITY (MARIBAVIR) — FDA approval

ENTYVIO (VEDOLIZUMAB) — FDA approval